Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | sphingoid long chain base kinase | 0.1927 | 1 | 0.5 |
Leishmania major | calcium channel protein, putative,ion transporter, putative | 0.1258 | 0 | 0.5 |
Schistosoma mansoni | sphingosine kinase A B | 0.1927 | 1 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.1927 | 1 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.1927 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1927 | 1 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.1927 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.1927 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 19.64 % | Inhibition of BACE1 using methoxycoumarin-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys-dinitrophenyl as substrate at 100 uM preincubated 1 hr before substrate addition measured after 15 mins by FRET assay | ChEMBL. | 22209418 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.